SUCLA2-deficient Pr...
Clear all

SUCLA2-deficient Prostate Cancer --- Thymoquinone

Joined: 2 years ago
Posts: 115
Topic starter  

Hi friends, just came across the following a few days ago, so sharing it here:

Advanced prostate cancer has an unexpected weakness that can be targeted by drugs

Researchers identified that SUCLA2-deficient prostate cancer cells can be selectively treated with thymoquinone

Date: October 7, 2020

Source: Kanazawa University


Researchers reported that the SUCLA2 gene is frequently involved in the deletion of the tumor suppressor gene RB1 in advanced prostate cancer.

RB1 deletion makes cells resistant to hormone therapy but SUCLA2 deletion induces a metabolic weakness.

The study showed that thymoquinone selectively killed SUCLA2-deficient prostate cancer cells in vitro and in vivo.

The findings highlight a vulnerability of advanced prostate cancer cells that can be targeted by drugs.



Just Sharing --- 1 Source of Supplement with the compound thymoquinone (TQ):


If interested in this supplement, please contact Daniel Stanciu (Founder of MCS Formulas & this great website) for further details / advice: